OXB - Ticker AI Digest

Oxford BioMedica PLC 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (OXB) 1
OXB 12:01
Oxford BioMedica PLC
2025 Annual General Meeting notification
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
OXB 06:01
Oxford BioMedica PLC
Preliminary results for the year ended 31 Dec 2024
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Oxford Biomedica, a global quality and innovation-led cell and gene therapy CDMO, released its preliminary results for the year ended December 31, 2024, highlighting strong commercial momentum and transformative financial performance. The companys revenue grew by 44% to £128.8 million, with an organic revenue growth of 81%. The operating EBITDA loss was £15.3 million for the full year, with a profit of £5.0 million achieved in the second half. The contracted value of client orders signed during 2024 reached approximately £186 million, reflecting a strong commercial momentum. The companys lentiviral vector development and manufacturing capabilities have expanded beyond the UK into the US and France. Oxford Biomedica reaffirmed its financial guidance, targeting a revenue CAGR of more than 35% for 2023-2026 and expecting operating EBITDA profitability in 2025.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 2
OXB 16:46
Oxford BioMedica PLC
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
OXB 07:53
Oxford BioMedica PLC
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 5
OXB 12:01
Oxford BioMedica PLC
2025 Annual General Meeting notification
OXB 16:46
Oxford BioMedica PLC
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
OXB 06:01
Oxford BioMedica PLC
Preliminary results for the year ended 31 Dec 2024
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Oxford Biomedica, a global quality and innovation-led cell and gene therapy CDMO, released its preliminary results for the year ended December 31, 2024, highlighting strong commercial momentum and transformative financial performance. The companys revenue grew by 44% to £128.8 million, with an organic revenue growth of 81%. The operating EBITDA loss was £15.3 million for the full year, with a profit of £5.0 million achieved in the second half. The contracted value of client orders signed during 2024 reached approximately £186 million, reflecting a strong commercial momentum. The companys lentiviral vector development and manufacturing capabilities have expanded beyond the UK into the US and France. Oxford Biomedica reaffirmed its financial guidance, targeting a revenue CAGR of more than 35% for 2023-2026 and expecting operating EBITDA profitability in 2025.
OXB 07:53
Oxford BioMedica PLC
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
OXB 06:01
Oxford BioMedica PLC
OXB Total Voting Rights

AI Crunch

Single-Ticker AI Crunch
OXB signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Oxford BioMedica PLC. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full OXB AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for OXB on 2025-04-28.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
755622208
Enterprise Value
327833340
Public Float
50.28
Broker Target
842.857
Shares Out
120899550
Long Interest
94
Short Interest
6
Exchange
LSE
Currency Code
GBX
ISIN
GB00BDFBVT43
Market
LSE - MAIN MARKET
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
2026-04-09
Net Debt
9756000.0
Cash
96884000.0
EPS
-0.27
Net Income
-30128000.0
Revenue
168741000.0
Enterprise Value
327833340
Trailing PE
-
Forward PE
208.3333
Price Sales TTM
4.478
Price Book MRQ
7.5706
EV Revenue
4.402
EV EBITDA
307.9558

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
34.1457
Institutions As Of
2025-11-03
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
4
Sale Director Dealing
3
Purchase TR1
10
Sale TR1
2
Broker Coverage Rows
8
Institution Holders Tracked
5
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit OXB.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-04-28 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Oxford BioMedica PLC has fresh news flow feeding the chart narrative.
12:01 Today's Catalyst 2025 Annual General Meeting notification
AI Charts Studio
OXB Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-04-28 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 129.46%
RSI Gauge
Price Change
AI Forecast